A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT05848011 · COMPLETED

Trial details

NCT number: NCT05848011
Sponsor: MacroGenics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Androgen-Independent Prostatic Cancer Androgen-Independent Prostatic Neoplasms Prostate Cancer Recurrent Androgen-Insensitive Prostatic Cance Androgen-Resistant Prostatic Cancer Hormone Refractory Prostatic Cancer Immunotherapy Immune Checkpoint Inhibitor Inhibitory Checkpoint Molecule

Start date: 2023-09-28
Primary completion: 2026-02-19
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.